Literature DB >> 19377466

WIP1 phosphatase is a negative regulator of NF-kappaB signalling.

Joanne Chew1, Subhra Biswas, Sathyavageeswaran Shreeram, Mahathir Humaidi, Ee Tsin Wong, Manprit Kaur Dhillion, Hsiangling Teo, Amit Hazra, Cheok Chit Fang, Eduardo López-Collazo, Dmitry V Bulavin, Vinay Tergaonkar.   

Abstract

Post-translational modifications of NF-kappaB through phosphorylations enhance its transactivation potential. Much is known about the kinases that phosphorylate NF-kappaB, but little is known about the phosphatases that dephosphorylate it. By using a genome-scale siRNA screen, we identified the WIP1 phosphatase as a negative regulator of NF-kappaB signalling. WIP1-mediated regulation of NF-kappaB occurs in both a p38-dependent and independent manner. Overexpression of WIP1 resulted in decreased NF-kappaB activation in a dose-dependent manner, whereas WIP1 knockdown resulted in increased NF-kappaB function. We show that WIP1 is a direct phosphatase of Ser 536 of the p65 subunit of NF-kappaB. Phosphorylation of Ser 536 is known to be essential for the transactivation function of p65, as it is required for recruitment of the transcriptional co-activator p300. WIP1-mediated regulation of p65 regulated binding of NF-kappaB to p300 and hence chromatin remodelling. Consistent with our results, mice lacking WIP1 showed enhanced inflammation. These results provide the first genetic proof that a phosphatase directly regulates NF-kappaB signalling in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19377466     DOI: 10.1038/ncb1873

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  40 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity.

Authors:  Vinay Tergaonkar; Ricardo G Correa; Masahito Ikawa; Inder M Verma
Journal:  Nat Cell Biol       Date:  2005-09       Impact factor: 28.824

Review 3.  NFkappaB pathway: a good signaling paradigm and therapeutic target.

Authors:  Vinay Tergaonkar
Journal:  Int J Biochem Cell Biol       Date:  2006       Impact factor: 5.085

4.  Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1).

Authors:  Linda Vermeulen; Gert De Wilde; Petra Van Damme; Wim Vanden Berghe; Guy Haegeman
Journal:  EMBO J       Date:  2003-03-17       Impact factor: 11.598

5.  Essential role of tuberous sclerosis genes TSC1 and TSC2 in NF-kappaB activation and cell survival.

Authors:  Sourav Ghosh; Vinay Tergaonkar; Carla V Rothlin; Ricardo G Correa; Virginie Bottero; Pradeep Bist; Inder M Verma; Tony Hunter
Journal:  Cancer Cell       Date:  2006-09       Impact factor: 31.743

6.  De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.

Authors:  Ingrid E Wertz; Karen M O'Rourke; Honglin Zhou; Michael Eby; L Aravind; Somasekar Seshagiri; Ping Wu; Christian Wiesmann; Rohan Baker; David L Boone; Averil Ma; Eugene V Koonin; Vishva M Dixit
Journal:  Nature       Date:  2004-07-18       Impact factor: 49.962

7.  The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.

Authors:  Andrew Kovalenko; Christine Chable-Bessia; Giuseppina Cantarella; Alain Israël; David Wallach; Gilles Courtois
Journal:  Nature       Date:  2003-08-14       Impact factor: 49.962

8.  Deactivation of the kinase IKK by CUEDC2 through recruitment of the phosphatase PP1.

Authors:  Hui-Yan Li; Hui Liu; Chen-Hui Wang; Ji-Yan Zhang; Jiang-Hong Man; Yan-Fei Gao; Pei-Jing Zhang; Wei-Hua Li; Jie Zhao; Xin Pan; Tao Zhou; Wei-Li Gong; Ai-Ling Li; Xue-Min Zhang
Journal:  Nat Immunol       Date:  2008-03-23       Impact factor: 25.606

9.  Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-kappa B.

Authors:  S Singh; B B Aggarwal
Journal:  J Biol Chem       Date:  1995-05-05       Impact factor: 5.157

10.  Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response.

Authors:  Simona Saccani; Ivan Marazzi; Amer A Beg; Gioacchino Natoli
Journal:  J Exp Med       Date:  2004-06-28       Impact factor: 14.307

View more
  71 in total

Review 1.  Inhibiting NF-κB activation by small molecules as a therapeutic strategy.

Authors:  Subash C Gupta; Chitra Sundaram; Simone Reuter; Bharat B Aggarwal
Journal:  Biochim Biophys Acta       Date:  2010-05-21

Review 2.  NF-κB addiction and its role in cancer: 'one size does not fit all'.

Authors:  M M Chaturvedi; B Sung; V R Yadav; R Kannappan; B B Aggarwal
Journal:  Oncogene       Date:  2010-12-20       Impact factor: 9.867

Review 3.  TNF biology, pathogenic mechanisms and emerging therapeutic strategies.

Authors:  George D Kalliolias; Lionel B Ivashkiv
Journal:  Nat Rev Rheumatol       Date:  2015-12-10       Impact factor: 20.543

4.  Role of wild-type p53-induced phosphatase 1 in cancer.

Authors:  Zhi-Peng Wang; Ye Tian; Jun Lin
Journal:  Oncol Lett       Date:  2017-07-27       Impact factor: 2.967

Review 5.  Injury-associated reacquiring of intestinal stem cell function.

Authors:  Ferenc Sipos; Györgyi Műzes
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

6.  LZAP is a novel Wip1 binding partner and positive regulator of its phosphatase activity in vitro.

Authors:  J Jacob Wamsley; Natalia Issaeva; Hanbing An; Xinyuan Lu; Lawrence A Donehower; Wendell G Yarbrough
Journal:  Cell Cycle       Date:  2016-12-27       Impact factor: 4.534

7.  WIP1 phosphatase is a critical regulator of adipogenesis through dephosphorylating PPARγ serine 112.

Authors:  Dahu Li; Lijun Zhang; Lun Xu; Lili Liu; Yunling He; Yiyao Zhang; Xin Huang; Tong Zhao; Liying Wu; Yongqi Zhao; Kuiwu Wu; Hui Li; Xiao Yu; Taiyun Zhao; Shenghui Gong; Ming Fan; Lingling Zhu
Journal:  Cell Mol Life Sci       Date:  2017-02-08       Impact factor: 9.261

8.  Nuclear factor-kappaB (NF-kappaB) is a novel positive transcriptional regulator of the oncogenic Wip1 phosphatase.

Authors:  Julie M Lowe; Hyukjin Cha; Qian Yang; Albert J Fornace
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

9.  WIP1 regulates the proliferation and invasion of nasopharyngeal carcinoma in vitro.

Authors:  Yongquan Zhang; Hong Sun; Guangxiang He; An Liu; Fengjun Wang; Lu Wang
Journal:  Tumour Biol       Date:  2014-05-07

10.  Acetylation of p65 at lysine 314 is important for late NF-kappaB-dependent gene expression.

Authors:  Karin M Rothgiesser; Monika Fey; Michael O Hottiger
Journal:  BMC Genomics       Date:  2010-01-11       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.